VieMed utilizes specialized technology-enabled remote patient monitoring (RPM) platforms and connected medical devices. These advanced systems allow clinical teams to track vital health metrics—such as blood oxygen saturation levels, respiratory rates, and ventilator compliance data—in real time from patients' homes, enabling early clinical interventions and reducing hospital readmission rates.
VieMed Healthcare, Inc. is led by Casey Hoyt, who serves as the Co-Founder and Chief Executive Officer.
VieMed Healthcare is a publicly traded corporate enterprise owned collectively by its public shareholders, institutional fund managers, and internal corporate insiders.
Yes, VieMed's primary corporate headquarters is situated in Lafayette, Louisiana. From this central operational hub, the company manages its nationwide logistics, patient care coordination, compliance divisions, and administrative leadership teams.
VieMed Healthcare's corporate headquarters is centrally located at 625 E. Kaliste Saloom Road, Lafayette, Louisiana 70508.
Employee feedback on workplace platforms like Glassdoor and Indeed generally leans positive, with staff praising supportive local management, meaningful work within respiratory patient care, and comprehensive healthcare benefits.
VMD stock operates within the Healthcare sector, specifically categorized under the Healthcare Providers & Services and Medical Equipment & Supplies industries.
Yes, VieMed offers comprehensive sleep apnea treatment equipment, including Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, masks, and recurring therapeutic resupply components.
VieMed Healthcare, Inc. is a specialized healthcare services company focused on treating chronic respiratory diseases and disorders.
VieMed delivers comprehensive in-home respiratory healthcare services, focusing on chronic conditions like chronic obstructive pulmonary disease (COPD), neuromuscular diseases, and sleep disorders.
Like many small-cap healthcare and medical technology equities, VieMed Healthcare (NASDAQ/TSX: VMD) experiences periods of market volatility.
VMD stock maintains a moderate volatility profile typical of small-cap healthcare equities.
VieMed Healthcare, Inc. (NASDAQ: VMD) trades at approximately $8.85 per share.
VieMed Healthcare (NASDAQ: VMD) does not currently pay a regular cash dividend to common shareholders.
VieMed Healthcare, Inc. is a specialized healthcare services company operating across the United States, focusing primarily on the treatment and management of chronic respiratory diseases.
VieMed Healthcare provides a comprehensive employee benefits package designed to support its corporate staff and clinical field personnel.
Trading under the ticker symbol VMD on the NASDAQ and TSX exchanges, VieMed Healthcare shares trade around $8.85 per share.
VieMed Healthcare's corporate headquarters is located at 625 E. Kaliste Saloom Rd., Lafayette, Louisiana 70508, United States.
Stock market volatility shifts constantly on a daily basis depending on active macroeconomic data releases, earnings surprises, and speculative trading volumes.
Yes, VieMed Healthcare is a completely legitimate, publicly traded enterprise listed on both the NASDAQ and the Toronto Stock Exchange under the ticker VMD.
Yes, VieMed Healthcare is a publicly traded corporation. It is listed on both the NASDAQ capital market and the Toronto Stock Exchange (TSX) under the common stock ticker symbol VMD.
Compensation for a VieMed Sales Representative in California varies depending on prior medical device sales experience, commission structures, and regional territory targets.
VieMed did not initiate a major corporate lawsuit, but it successfully navigated a multi-year administrative and legal defense process contesting a 2021 Office of Inspector General (OIG) audit report. A U.S.
Equity research analysts covering VieMed Healthcare, Inc. (NASDAQ/TSX: VMD) maintain positive consensus forecasts, with average 12-month institutional price targets hovering around $11.00 per share.
Equity research analysts tracking VieMed Healthcare, Inc. (NASDAQ/TSX: VMD) maintain positive consensus ratings with an average 12-month target price around $11.00 per share.